Fate Therapeutics
FATE
FATE
116 hedge funds and large institutions have $893M invested in Fate Therapeutics in 2018 Q3 according to their latest regulatory filings, with 27 funds opening new positions, 43 increasing their positions, 26 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
14% more call options, than puts
Call options by funds: $2.77M | Put options by funds: $2.43M
13% more funds holding
Funds holding: 103 → 116 (+13)
5.85% more ownership
Funds ownership: 81.42% → 87.27% (+5.8%)
Holders
116
Holding in Top 10
4
Calls
$2.77M
Puts
$2.43M
Top Buyers
| 1 | +$60.3M | |
| 2 | +$24.5M | |
| 3 | +$19.1M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$16.5M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$11M |
Top Sellers
| 1 | -$8.57M | |
| 2 | -$2.81M | |
| 3 | -$2.54M | |
| 4 |
6CM
683 Capital Management
New York
|
-$1.53M |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$1.16M |